Report cover image

Tissue Diagnostics Market Growth, Size, Trends Analysis - By Technology, By Application, By Modality, By End Use - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Publisher SPER Market Research Pvt. Ltd.
Published Feb 17, 2025
Length 260 Pages
SKU # SPER19876755

Description

Tissue Diagnostics Market Introduction and Overview

According to SPER market research, ‘Global Tissue Diagnostics Market Size- By Technology, By Application, By Modality, By End Use – Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the Global Tissue Diagnostics Market is predicted to reach 20.08 Billion by 2034 with a CAGR of 8.7%.

Tissue diagnostics is a medical practice that examines tissue samples for signs of disease, particularly cancer. It involves looking at tissue biopsies under a microscope to find abnormal cells and determine their characteristics, often using specific staining methods. This process enables precise disease identification, staging, and assessment of a tumor’s prospective response to particular therapy.

Restraints:One of the biggest challenges for organizations launching novel tissue diagnostic technologies is navigating regulatory environments. The FDA’s stringent approval procedure poses a significant obstacle, especially for Class III devices that need premarket approval. Current guideline documents make things considerably more difficult by requiring 510(k) submissions for even small device modifications.

Scope of the Report:

Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034
Segments covered By Technology, By Application, By Modality, By End Use.

Regions covered

North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa.

Companies Covered

Abbott Laboratories, Agilent Technologies, BD, Bio SB, BioGenex, bioMerieux SA, Cell Signaling Technology, Inc., Danaher, DiaGenic ASA, F. Hoffmann-La Roche Ltd., GE Healthcare, Merck KGaA, QIAGEN, and Others.

Tissue Diagnostics Market Segmentation:

By Technology:Based on the Technology, Global Tissue Diagnostics Market is segmented as; Immunohistochemistry, In Situ Hybridization, Primary & Special Staining, Digital Pathology and Workflow, Anatomic Pathology, Molecular Pathology.

By Application:Based on the Application, Global Tissue Diagnostics Market is segmented as; Breast Cancer, Non-small Cell Lung Cancer, Prostate Cancer, Gastric Cancer, Other Cancers.

By Modality:Based on the Modality, Global Tissue Diagnostics Market is segmented as; Clinical, Pharma / CRO / Research Market.

By End Use:Based on the End Use, Global Tissue Diagnostics Market is segmented as; (Hospitals, Diagnostic Center, Pharmaceutical Organizations, Contract Research Organizations (CROs).

By Region:This research also includes data for North America, Latin America, Asia-Pacific, Europe and Middle East & Africa.

Table of Contents

260 Pages
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Tissue Diagnostics Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Tissue Diagnostics Market
7. Global Tissue Diagnostics Market, By Technology, (USD Million) 2021-2034
7.1. Immunohistochemistry
7.2. In Situ Hybridization
7.3. Primary & Special Staining
7.4. Digital Pathology and Workflow
7.5. Anatomic Pathology
7.6. Molecular Pathology
8. Global Tissue Diagnostics Market, By Application, (USD Million) 2021-2034
8.1. Breast Cancer
8.2. Non-small Cell Lung Cancer
8.3. Prostate Cancer
8.4. Gastric Cancer
8.5. Other Cancers
9. Global Tissue Diagnostics Market, By Modality, (USD Million) 2021-2034
9.1. Clinical
9.2. Pharma / CRO / Research Market
10. Global Tissue Diagnostics Market, By End Use, (USD Million) 2021-2034
10.1. Hospitals
10.2. Diagnostic Center
10.3. Pharmaceutical Organizations
10.4. Contract Research Organizations (CROs)
11. Global Tissue Diagnostics Market, (USD Million) 2021-2034
11.1. Global Tissue Diagnostics Market Size and Market Share
12. Global Tissue Diagnostics Market, By Region, (USD Million) 2021-2034
12.1. Asia-Pacific
12.1.1. Australia
12.1.2. China
12.1.3. India
12.1.4. Japan
12.1.5. South Korea
12.1.6. Rest of Asia-Pacific
12.2. Europe
12.2.1. France
12.2.2. Germany
12.2.3. Italy
12.2.4. Spain
12.2.5. United Kingdom
12.2.6. Rest of Europe
12.3. Middle East and Africa
12.3.1. Kingdom of Saudi Arabia
12.3.2. United Arab Emirates
12.3.3. Qatar
12.3.4. South Africa
12.3.5. Egypt
12.3.6. Morocco
12.3.7. Nigeria
12.3.8. Rest of Middle-East and Africa
12.4. North America
12.4.1. Canada
12.4.2. Mexico
12.4.3. United States
12.5. Latin America
12.5.1. Argentina
12.5.2. Brazil
12.5.3. Rest of Latin America
13. Company Profile
13.1. Abbott Laboratories
13.1.1. Company details
13.1.2. Financial outlook
13.1.3. Product summary
13.1.4. Recent developments
13.2. Agilent Technologies
13.2.1. Company details
13.2.2. Financial outlook
13.2.3. Product summary
13.2.4. Recent developments
13.3. BD
13.3.1. Company details
13.3.2. Financial outlook
13.3.3. Product summary
13.3.4. Recent developments
13.4. Bio SB
13.4.1. Company details
13.4.2. Financial outlook
13.4.3. Product summary
13.4.4. Recent developments
13.5. BioGenex
13.5.1. Company details
13.5.2. Financial outlook
13.5.3. Product summary
13.5.4. Recent developments
13.6. bioMerieux SA
13.6.1. Company details
13.6.2. Financial outlook
13.6.3. Product summary
13.6.4. Recent developments
13.7. Cell Signaling Technology, Inc.
13.7.1. Company details
13.7.2. Financial outlook
13.7.3. Product summary
13.7.4. Recent developments
13.8. Danaher
13.8.1. Company details
13.8.2. Financial outlook
13.8.3. Product summary
13.8.4. Recent developments
13.9. DiaGenic ASA
13.9.1. Company details
13.9.2. Financial outlook
13.9.3. Product summary
13.9.4. Recent developments
13.10. F. Hoffmann-La Roche Ltd.
13.10.1. Company details
13.10.2. Financial outlook
13.10.3. Product summary
13.10.4. Recent developments
13.11. GE Healthcare
13.11.1. Company details
13.11.2. Financial outlook
13.11.3. Product summary
13.11.4. Recent developments
13.12. Merck KGaA
13.12.1. Company details
13.12.2. Financial outlook
13.12.3. Product summary
13.12.4. Recent developments
13.13. QIAGEN
13.13.1. Company details
13.13.2. Financial outlook
13.13.3. Product summary
13.13.4. Recent developments
13.14. Others
14. Conclusion
15. List of Abbreviations
16. Reference Links

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us